Total planned funding: $1,055,953,224
Clear active filters
Unknown
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $317,485,595 |
Tanzania | $138,732,211 |
Kenya | $95,776,659 |
Uganda | $91,045,294 |
Nigeria | $90,133,177 |
Zimbabwe | $55,871,779 |
Mozambique | $43,830,625 |
Zambia | $32,721,367 |
Haiti | $26,919,157 |
Malawi | $21,169,175 |
Ethiopia | $18,881,228 |
Cameroon | $16,533,704 |
Botswana | $14,656,119 |
Namibia | $12,808,136 |
Democratic Republic of the Congo | $10,993,746 |
Burundi | $10,140,422 |
Lesotho | $9,249,958 |
Vietnam | $7,654,455 |
Ukraine | $5,653,093 |
Eswatini | $5,484,149 |
Côte d'Ivoire | $5,369,133 |
Cambodia | $4,659,203 |
Ghana | $4,375,000 |
Rwanda | $4,325,966 |
Central Asia Region | $3,800,000 |
India | $2,850,000 |
South Sudan | $2,227,942 |
Central America Region | $2,080,931 |
Angola | $375,000 |
Caribbean Region | $150,000 |
Organizational Types
Unknown | $1,055,953,224 |
Program Areas
Treatment | $371,965,311 |
Care | $257,799,370 |
Prevention | $211,300,306 |
Governance and Systems | $129,894,682 |
Testing | $99,191,668 |
Budget Codes
HTXS: Treatment: Adult Treatment | $283,261,958 |
HKID: Care: Orphans and Vulnerable Children | $130,944,458 |
HVCT: Testing: HIV Testing and Counseling | $99,191,668 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $73,443,818 |
HVOP: Sexual Prevention: Other Sexual Prevention | $69,244,727 |
HBHC: Care: Adult Care and Support | $66,604,539 |
HVSI: Strategic Information | $59,994,141 |
HTXD: Treatment: ARV Drugs | $53,268,973 |
OHSS: Health Systems Strengthening | $46,393,701 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $46,369,631 |
HVTB: Care: TB/HIV | $42,218,797 |
PDTX: Treatment: Pediatric Treatment | $35,434,380 |
HLAB: Laboratory Infrastructure | $23,506,840 |
PDCS: Care: Pediatric Care and Support | $18,031,576 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,582,991 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,059,940 |
HMBL: Biomedical Prevention: Blood Safety | $1,512,284 |
HMIN: Biomedical Prevention: Injection Safety | $86,915 |